Chung-Han Lee, MD, PhD, discusses second-line treatment options in renal cell carcinoma.
Chung-Han (Joe) Lee, MD, PhD
Advertisement
Articles by Chung-Han (Joe) Lee, MD, PhD
Advertisement
Latest Updated Articles
Dr. Lee on Second-Line Treatment Options in RCCPublished: May 12th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5